Global Metabolic
Testing Market, by Product Type (Metabolic Carts (Portable and Bench-top),
Body Composition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portable
and Bench-top)), by Test Type (VO2 Max Analysis, RMR Analysis, and Body
Composition Analysis), by End User (Hospitals & Clinics, Sports Performance
Lab, and Home Care Settings), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 451.5 Mn in
2018, and is projected to exhibit a CAGR of 7.6% during the forecast period
(2018–2026).
Increasing launch of advanced
metabolic testing devices and high prevalence of lifestyle diseases is expected
to support the global metabolic testing market growth. Major players in the
market are also focused on investing in research and development of novel
metabolic testing devices. For instance, in 2017, InBody Co., Ltd. introduced
InBody band 2, which is a fusion of body composition analyzers and fitness
trackers. In March 2018, Cosmed srl launched Q-NRG — a metabolic monitor for
measuring energy expenditure in spontaneous breathing and mechanically ventilated
patients admitted in ICU.
Browse 35 Market Data Tables and
34 Figures spread through 179 Pages and in-depth TOC on Global Metabolic
Testing Market by Product Type (Metabolic Carts (Portable and Bench-top), Body
Composition Analyzers (Portable and Bench-top), and ECGs/EKGs (Portable and Bench-top)),
by Test Type (VO2 Max Analysis, RMR Analysis, and Body Composition Analysis),
by End User (Hospitals & Clinics, Sports Performance Lab, and Home Care
Settings), and by Region (North America, Latin America, Europe, Asia Pacific,
the Middle East, and Africa) - Global Forecast to 2026
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1652
High prevalence of lifestyle
diseases is expected to propel demand for metabolic testing systems which in
turn is expected to support global metabolic testing market growth over the
forecast period. For instance, according to a report published by Stroke
Alliance for Europe (SAFE) in 2017, incidence of stroke is expected to increase
by 34% in Europe during 2015-2035. Moreover, according to the same source,
number of people living with stroke is expected to increase by around 25%
between 2015 and 2035 from 3,718,785 million in 2015 to 4,631,050 by 2035. Key
players in the market are focused on adopting merger and acquisition strategies
in order to expand their product portfolio and enhance their market share. For
instance, In May 2018, GE Healthcare announced a marketing collaboration agreement
with FitTrace, a company that offers cloud-based software for analysis and
reporting of body composition. Restraints Lifestyle diseases are still not
considered as extremely serious and fatal in developed as well as emerging
economies. Low awareness among people regarding metabolic testing and need for
screening, prevention, and monitoring of lifestyle diseases is also expected to
restrain the market growth.
Two test are majorly
conducted/used in metabolic testing. Resting Metabolic Rate (RMR) analysis is
required in ICUs for hospitalized patients to track their health status and to
devise precise nutritional requirements for such patients on the basis of their
RMR analysis. VO2 max analysis is required by sports professionals and
athletes. (so, these two tests have limited target population which may
restrain growth of the market). Body composition analysis is not performed
extensively other than by fitness enthusiasts (to have high muscle to fat ratio
for a muscular physique) and other purposes. These factors are expected to
restrain growth of the market up to certain extent.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/metabolic-testing-market-1652
Key Takeaways of the Metabolic
Testing Market:
The global metabolic testing
market is expected to exhibit a CAGR of 7.6% during the forecast period (2018 –
2026), owing to increasing product launches and approvals and robust pipeline
of novel metabolic testing devices
North America metabolic testing
market is expected to hold dominant position in the global metabolic testing
market over the forecast period. This is due to presence of large customer base
and key players in the region that are increasingly focused on new product
launches. For instance, in January 2019, KORR Medical Technologies launched
Metabolic Meal Plan application, which can help clinicians to implement, manage,
and track clients’ weight-loss regimens.
Europe metabolic testing market
is expected to account for the second largest market share in the global
metabolic testing market due to presence of key manufacturers and their active
focus on research and development of new products. For instance, in November
2017, Vizient, Inc., a major healthcare performance improvement company,
bestowed '2017 Innovative Technology designation' to COSMED srl’s K5 wearable
metabolic system.
Major players operating in the
metabolic testing market include, COSMED srl, Vyaire Medical, Inc., Geratherm
Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General
Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc.,
AEI Technologies, Inc., and KORR Medical Technologies, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1652
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent Market
Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment